Related Experiment Video

Updated: Aug 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle

Xin Hu1, Sharlene Washington, Michael F Verderame

  • 1Department of Medicine, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.

Cancer Research
|December 3, 2005
PubMed

Insights

Alpha-difluoromethylornithine (DFMO) inhibits breast cancer cell proliferation by depleting polyamines, causing cell cycle arrest. The mitogen-activated protein kinase (MAPK) pathway mediates some DFMO effects, but alternative mechanisms also contribute to cell cycle suppression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Cycle Regulation

Background:

  • Alpha-difluoromethylornithine (DFMO) inhibits polyamine biosynthesis and breast cancer cell proliferation.
  • The precise mechanism of DFMO's action on breast cancer cell cycle progression remains incompletely understood.
  • The mitogen-activated protein kinase (MAPK) pathway is implicated in mediating some cellular responses to DFMO.

Purpose of the Study:

  • To investigate the effects of DFMO on cell cycle variables in MDA-MB-435 human breast cancer cells.
  • To elucidate the role of the MAPK pathway in mediating DFMO's impact on breast cancer cell cycle progression.
  • To determine the specific molecular mechanisms underlying DFMO-induced cell cycle arrest.

Main Methods:

  • Treatment of MDA-MB-435 cells with DFMO and MAPK inhibitors (PD98059, U0126).
  • Analysis of cell cycle regulators including p53, p21, cyclin E, cyclin-dependent kinase (cdk)-2, retinoblastoma (Rb) protein, and p27.
  • Assessment of protein expression, phosphorylation, complex formation, and kinase activity.

Main Results:

  • DFMO induced p53-independent p21 expression, decreased cdk-2 and cyclin E levels, reduced Rb phosphorylation, and caused G1-S and G2-M cell cycle arrest.
  • These DFMO effects were reversible by putrescine, confirming polyamine depletion as the cause.
  • MAPK pathway inhibition partially reversed DFMO-induced G2-M arrest by affecting p21 but not the G1-S arrest, indicating alternative mechanisms.

Conclusions:

  • DFMO-induced cell cycle arrest in breast cancer cells involves both MAPK-dependent and -independent pathways.
  • MAPK pathway activation contributes to DFMO's effects on p21 induction and cdk-2 reduction.
  • Alternative mechanisms are crucial for the complete suppression of cdk-2 activity and cell cycle arrest induced by DFMO.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...